Generic OZEMPIC
On this page
What the application record shows
A generic medicine reaches the American market through an abbreviated new drug application, an ANDA, which is how a second company gets approval to sell a copy of a drug another company developed. Brand products go through a new drug application, an NDA. Drugs@FDA publishes both, and on 12 September 2026 it held six applications for products with semaglutide as an active ingredient.4
| Application | Sponsor | Products | Status |
|---|---|---|---|
| ANDA220314 | Apotex | Semaglutide injection, three strengths | Tentative approval, 7 April 2026. Not marketed. |
| NDA209637 | Novo Nordisk | OZEMPIC | Approved 5 December 2017 |
| NDA213051 | Novo Nordisk | OZEMPIC, RYBELSUS | Approved 20 September 2019 |
| NDA213182 | Novo Nordisk | RYBELSUS | Approved 16 January 2020 |
| NDA215256 | Novo Nordisk | WEGOVY, WEGOVY FlexTouch, WEGOVY HD | Approved 4 June 2021 |
| NDA218316 | Novo Nordisk | WEGOVY | Approved 22 December 2025 |
Drugs@FDA through the openFDA API, query on active ingredient SEMAGLUTIDE, read 12 September 2026; the response carries its own currency date, 11 September 2026. It is listed under Sources with the controls that were run beside it.
The Apotex row is the one worth reading twice, because it is both more and less than people expect. More, because an ANDA for semaglutide exists and a common answer to this question is that none does. Less, because the record lists its three injection strengths with a marketing status of “None (Tentative Approval)” while all five Novo applications carry “Prescription”. A tentative approval is not a product you can be handed at a pharmacy, and the record does not say when or whether that changes.4
Compounded is not generic
The semaglutide sold for a fraction of the brand price is usually compounded: mixed by a pharmacy rather than manufactured under one of the applications above. The two words get used as though they meant the same thing, and FDA’s own page draws the line:
A compounded drug might be appropriate if a patient’s medical need cannot be met by an FDA-approved drug, or the FDA-approved drug is not commercially available. However, compounded drugs are not FDA approved. This means the agency does not review compounded drugs for safety, effectiveness or quality before they are marketed.
A generic is reviewed before it is sold, against the brand it copies. A compounded preparation is not reviewed before it is sold at all. Whatever else separates them, that single sentence is the difference a price cannot show you, and it is why a plan’s drug list, which is a list of approved products, treats them differently — which product the prescription names is one of the four things a plan is deciding. The compounded semaglutide page covers what the category is and how to tell which one you were sent. For the broader distinction, read FDA-approved versus compounded semaglutide.
What that means for the prices you are seeing
Of the 92 sellers priced on this site, 36 state that what they dispense is compounded and 2 state branded. A page advertising “generic Ozempic” at a fraction of the brand price is almost certainly describing the first kind, and the word generic is doing work the product cannot support. The rest of the roster states neither word, and how many sellers say which product a figure is for is counted there against the whole roster.
The brand prices themselves are published and dated: what OZEMPIC costs and what WEGOVY costs carry the manufacturer’s own figures with the day they were read. If the gap between those and a telehealth number is the reason you are here, the honest comparison starts with knowing the two are not the same product, which is one of the reasons two semaglutide prices are usually not comparable.
Questions
Is there a generic version of OZEMPIC?
Not one you can buy. Drugs@FDA lists one abbreviated application for semaglutide injection, from Apotex, recorded as tentatively approved on 7 April 2026 with a marketing status of None (Tentative Approval). The five applications behind the products on pharmacy shelves are all Novo Nordisk’s.4
Is compounded semaglutide the same as generic semaglutide?
No. A generic is approved under an abbreviated application and reviewed against the brand before it is sold. FDA states that compounded drugs are not FDA approved and are not reviewed for safety, effectiveness or quality before they are marketed.1
When will a generic be available?
The application record does not say, and neither does this page. A tentative approval means the product is not marketed; what has to happen before that changes is not stated in the record that was read.
Read next
Sources
A reference, not medical advice, and not a substitute for your prescriber or pharmacist. If you think you are having a medical emergency, call your local emergency number.